US healthcare CDMO market is projected to grow at a significant CAGR during the forecast period. The outsourcing services is one of the fastest-growing markets within the pharmaceutical and biotechnology industries and the contract manufacturing segment represents a significant portion of the outsourcing market. There has been a significant shift in the way companies are looking to outsource and this differs significantly across tiers and types of companies.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/us-healthcare-cdmo-market
Pharmaceutical contract manufacturing in the US is fueled by an increase in biotechnology companies. These companies are dedicated to developing drug compounds for specific therapeutic areas. However, these companies lack infrastructure in the areas of formulation, clinical and regulatory agency submission.
With the biotechnology and pharmaceutical industries striving for cost minimization and profit maximization, outsourcing production has become an ever-increasing trend as these are striving for cost minimization and profit maximization. The US is one of the largest pharmaceutical industries, is dependent on other countries for products such as the countries in the Asia-Pacific region. A shift has been observed to outsource manufacturing capabilities to CDMOs in the Asia-Pacific region, specifically in India. Cost benefits owing to low labor costs and capital expenditures are the key reasons for outsourcing to the Asia-Pacific region. Hence, the CDMOs, by providing low-services and without compromising with the quality, may create ample opportunity for the growth of the market in the near future.
Key Questions Addressed by the Report
- What is the market growth rate during the forecast period?
- Which segment dominates the market in the base year?
- Which segment will project the fastest growth in the market during the forecast period?
- How COVID-19 will impact the market growth in 2020 and the coming years?
o Recovery Timeline
o Deviation from the pre-COVID forecast
o Most affected region/segment
o Recommendations
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
US healthcare CDMO Market – Segmentation
By Services
- Contract Development
o Clinical
o Preclinical
o Laboratory Services
- Contract Manufacturing
o Active Pharmaceutical Ingredients( API)
o Finish Dosage Formulations
o Medical Devices
A full report of US Healthcare CDMO Market is available at: https://www.omrglobal.com/industry-reports/us-healthcare-cdmo-market
Company Profiles
- AbbVie Inc.
- Baxter International, Inc.
- Catalent Inc.
- Covance Inc.
- Cambrex Corp.
- Hisun Pharmaceuticals Inc.
- Jabil Inc.
- Pfizer Inc.
- Stason Pharmaceuticals, Inc.
- Thermo Fisher Scientific Inc.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
